ID   AAK1_HUMAN              Reviewed;         961 AA.
AC   Q2M2I8; Q4ZFZ3; Q53RX6; Q9UPV4;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 3.
DT   12-APR-2017, entry version 117.
DE   RecName: Full=AP2-associated protein kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=Adaptor-associated kinase 1;
GN   Name=AAK1; Synonyms=KIAA1048;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
RP   CLATHRIN, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=17494869; DOI=10.1091/mbc.E06-09-0831;
RA   Henderson D.M., Conner S.D.;
RT   "A novel AAK1 splice variant functions at multiple steps of the
RT   endocytic pathway.";
RL   Mol. Biol. Cell 18:2698-2706(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   GLN-509.
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   GLN-509.
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND MUTAGENESIS OF LYS-74 AND ASP-176.
RX   PubMed=12952931; DOI=10.1083/jcb.200304069;
RA   Conner S.D., Schmid S.L.;
RT   "Differential requirements for AP-2 in clathrin-mediated
RT   endocytosis.";
RL   J. Cell Biol. 162:773-779(2003).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-389 AND THR-606, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-389, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-637, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-389; THR-441; SER-637
RP   AND SER-731, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-234; SER-235; THR-389;
RP   THR-606; THR-620; SER-623; SER-624 AND SER-637, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   FUNCTION, INTERACTION WITH NUMB, AND MUTAGENESIS OF LYS-74 AND
RP   ASP-176.
RX   PubMed=18657069; DOI=10.1111/j.1600-0854.2008.00790.x;
RA   Sorensen E.B., Conner S.D.;
RT   "AAK1 regulates Numb function at an early step in clathrin-mediated
RT   endocytosis.";
RL   Traffic 9:1791-1800(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; THR-354; THR-389;
RP   SER-637; SER-650; TYR-687 AND SER-731, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-389; THR-606; SER-637
RP   AND THR-653, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-620; SER-623; SER-624
RP   AND SER-637, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   FUNCTION, INTERACTION WITH EPS15 AND NOTCH1, AND MUTAGENESIS OF LYS-74
RP   AND 777-ASP--PHE-779.
RX   PubMed=21464124; DOI=10.1074/jbc.M110.190769;
RA   Gupta-Rossi N., Ortica S., Meas-Yedid V., Heuss S., Moretti J.,
RA   Olivo-Marin J.C., Israel A.;
RT   "The adaptor-associated kinase 1, AAK1, is a positive regulator of the
RT   Notch pathway.";
RL   J. Biol. Chem. 286:18720-18730(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-606; THR-620; SER-624
RP   AND SER-637, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; THR-606; THR-620 AND
RP   SER-637, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-620, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-59; HIS-533; ALA-603; MET-694;
RP   THR-725; ARG-771 AND ASP-835.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Regulates clathrin-mediated endocytosis by
CC       phosphorylating the AP2M1/mu2 subunit of the adaptor protein
CC       complex 2 (AP-2) which ensures high affinity binding of AP-2 to
CC       cargo membrane proteins during the initial stages of endocytosis.
CC       Isoform 1 and isoform 2 display similar levels of kinase activity
CC       towards AP2M1. Regulates phosphorylation of other AP-2 subunits as
CC       well as AP-2 localization and AP-2-mediated internalization of
CC       ligand complexes. Phosphorylates NUMB and regulates its cellular
CC       localization, promoting NUMB localization to endosomes. Binds to
CC       and stabilizes the activated form of NOTCH1, increases its
CC       localization in endosomes and regulates its transcriptional
CC       activity. {ECO:0000269|PubMed:12952931,
CC       ECO:0000269|PubMed:17494869, ECO:0000269|PubMed:18657069,
CC       ECO:0000269|PubMed:21464124}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Stimulated by clathrin. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with alpha-adaptin, AP-2, clathrin, NUMB and
CC       EPS15 isoform 2. Interacts with membrane-bound activated NOTCH1
CC       but not with the inactive full-length form of NOTCH1.
CC       Preferentially interacts with monoubiquitinated activated NOTCH1
CC       compared to the non-ubiquitinated form.
CC       {ECO:0000269|PubMed:17494869, ECO:0000269|PubMed:18657069,
CC       ECO:0000269|PubMed:21464124}.
CC   -!- INTERACTION:
CC       Q9NQ11:ATP13A2; NbExp=2; IntAct=EBI-1383433, EBI-6308763;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}. Membrane, clathrin-coated pit
CC       {ECO:0000250}. Note=Active when found in clathrin-coated pits at
CC       the plasma membrane. In neuronal cells, enriched at presynaptic
CC       terminals. In non-neuronal cells, enriched at leading edge of
CC       migrating cells (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=AAK1L;
CC         IsoId=Q2M2I8-1; Sequence=Displayed;
CC       Name=2; Synonyms=AAK1S;
CC         IsoId=Q2M2I8-2; Sequence=VSP_039459;
CC   -!- TISSUE SPECIFICITY: Detected in brain, heart and liver. Isoform 1
CC       is the predominant isoform in brain.
CC       {ECO:0000269|PubMed:17494869}.
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA83000.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB028971; BAA83000.2; ALT_INIT; mRNA.
DR   EMBL; AC092431; AAX88861.1; -; Genomic_DNA.
DR   EMBL; AC079121; AAY14931.1; -; Genomic_DNA.
DR   EMBL; AC136007; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC104842; AAI04843.1; -; mRNA.
DR   EMBL; BC111965; AAI11966.1; -; mRNA.
DR   CCDS; CCDS1893.2; -. [Q2M2I8-1]
DR   RefSeq; NP_055726.3; NM_014911.3.
DR   UniGene; Hs.468878; -.
DR   PDB; 4WSQ; X-ray; 1.95 A; A/B=29-345.
DR   PDB; 5L4Q; X-ray; 1.97 A; A/B=27-365.
DR   PDB; 5TE0; X-ray; 1.90 A; A=27-365.
DR   PDBsum; 4WSQ; -.
DR   PDBsum; 5L4Q; -.
DR   PDBsum; 5TE0; -.
DR   ProteinModelPortal; Q2M2I8; -.
DR   SMR; Q2M2I8; -.
DR   BioGrid; 116520; 24.
DR   IntAct; Q2M2I8; 21.
DR   STRING; 9606.ENSP00000386456; -.
DR   BindingDB; Q2M2I8; -.
DR   ChEMBL; CHEMBL3830; -.
DR   GuidetoPHARMACOLOGY; 1921; -.
DR   iPTMnet; Q2M2I8; -.
DR   PhosphoSitePlus; Q2M2I8; -.
DR   SwissPalm; Q2M2I8; -.
DR   BioMuta; AAK1; -.
DR   DMDM; 300669613; -.
DR   EPD; Q2M2I8; -.
DR   MaxQB; Q2M2I8; -.
DR   PaxDb; Q2M2I8; -.
DR   PeptideAtlas; Q2M2I8; -.
DR   PRIDE; Q2M2I8; -.
DR   Ensembl; ENST00000406297; ENSP00000385181; ENSG00000115977. [Q2M2I8-2]
DR   Ensembl; ENST00000409085; ENSP00000386456; ENSG00000115977. [Q2M2I8-1]
DR   GeneID; 22848; -.
DR   KEGG; hsa:22848; -.
DR   UCSC; uc002sfp.3; human. [Q2M2I8-1]
DR   CTD; 22848; -.
DR   DisGeNET; 22848; -.
DR   GeneCards; AAK1; -.
DR   H-InvDB; HIX0161871; -.
DR   HGNC; HGNC:19679; AAK1.
DR   HPA; HPA017931; -.
DR   HPA; HPA020289; -.
DR   MIM; 616405; gene.
DR   neXtProt; NX_Q2M2I8; -.
DR   OpenTargets; ENSG00000115977; -.
DR   PharmGKB; PA134990616; -.
DR   eggNOG; KOG1989; Eukaryota.
DR   eggNOG; ENOG410Y515; LUCA.
DR   GeneTree; ENSGT00870000136426; -.
DR   HOGENOM; HOG000232173; -.
DR   HOVERGEN; HBG080803; -.
DR   InParanoid; Q2M2I8; -.
DR   KO; K08853; -.
DR   OMA; QAPIRQQ; -.
DR   OrthoDB; EOG091G02KI; -.
DR   PhylomeDB; Q2M2I8; -.
DR   TreeFam; TF317300; -.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   SignaLink; Q2M2I8; -.
DR   SIGNOR; Q2M2I8; -.
DR   ChiTaRS; AAK1; human.
DR   GeneWiki; AAK1; -.
DR   GenomeRNAi; 22848; -.
DR   PRO; PR:Q2M2I8; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115977; -.
DR   CleanEx; HS_AAK1; -.
DR   ExpressionAtlas; Q2M2I8; baseline and differential.
DR   Genevisible; Q2M2I8; HS.
DR   GO; GO:0031252; C:cell leading edge; ISS:UniProtKB.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0030136; C:clathrin-coated vesicle; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0019897; C:extrinsic component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043195; C:terminal bouton; ISS:UniProtKB.
DR   GO; GO:0035612; F:AP-2 adaptor complex binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005112; F:Notch binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IDA:UniProtKB.
DR   GO; GO:2000369; P:regulation of clathrin-dependent endocytosis; IDA:UniProtKB.
DR   GO; GO:0032880; P:regulation of protein localization; IDA:UniProtKB.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell membrane; Coated pit; Complete proteome; Endocytosis; Kinase;
KW   Membrane; Methylation; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    961       AP2-associated protein kinase 1.
FT                                /FTId=PRO_0000250578.
FT   DOMAIN       46    315       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      52     60       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS     12     42       Gly-rich.
FT   COMPBIAS    397    614       Gln-rich.
FT   COMPBIAS    658    663       Poly-Ala.
FT   ACT_SITE    176    176       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      74     74       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     234    234       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     235    235       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     354    354       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     389    389       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     391    391       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q3UHJ0}.
FT   MOD_RES     441    441       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     606    606       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     618    618       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P0C1X8}.
FT   MOD_RES     620    620       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     623    623       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     624    624       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     637    637       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     650    650       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     653    653       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     687    687       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     731    731       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES     846    846       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3UHJ0}.
FT   MOD_RES     937    937       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3UHJ0}.
FT   MOD_RES     938    938       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3UHJ0}.
FT   VAR_SEQ     823    961       EKADVAVESLIPGLEPPVPQRLPSQTESVTSNRTDSLTGED
FT                                SLLDCSLLSNPTTDLLEEFAPTAISAPVHKAAEDSNLISGF
FT                                DVPEGSDKVAEDEFDPIPVLITKNPQGGHSRNSSGSSESSL
FT                                PNLARSLLLVDQLIDL -> GKVIISVSSVMHDMCACFKND
FT                                KYLVNQSLGNSPATPEAKAI (in isoform 2).
FT                                {ECO:0000303|PubMed:10470851,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_039459.
FT   VARIANT      59     59       I -> V (in dbSNP:rs34535244).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040348.
FT   VARIANT     509    509       K -> Q (in dbSNP:rs6715776).
FT                                {ECO:0000269|PubMed:10470851,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031129.
FT   VARIANT     533    533       Q -> H. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040349.
FT   VARIANT     603    603       V -> A (in dbSNP:rs56038532).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040350.
FT   VARIANT     694    694       T -> M (in dbSNP:rs55889248).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040351.
FT   VARIANT     725    725       P -> T (in dbSNP:rs35285785).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040352.
FT   VARIANT     771    771       P -> R (in dbSNP:rs34422616).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040353.
FT   VARIANT     835    835       G -> D. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040354.
FT   MUTAGEN      74     74       K->A: Inhibits autophosphorylation and
FT                                phosphorylation of AP2M1. Does not affect
FT                                NUMB localization. Does not interact with
FT                                monoubiquitinated NOTCH1.
FT                                {ECO:0000269|PubMed:12952931,
FT                                ECO:0000269|PubMed:18657069,
FT                                ECO:0000269|PubMed:21464124}.
FT   MUTAGEN     176    176       D->A: Inhibits autophosphorylation and
FT                                phosphorylation of AP2M1. Does not affect
FT                                NUMB localization.
FT                                {ECO:0000269|PubMed:12952931,
FT                                ECO:0000269|PubMed:18657069}.
FT   MUTAGEN     777    779       DPF->AAA: Does not affect interaction
FT                                with NOTCH1 but abolishes interaction
FT                                with ESP15.
FT                                {ECO:0000269|PubMed:21464124}.
FT   HELIX        31     34       {ECO:0000244|PDB:5TE0}.
FT   STRAND       38     41       {ECO:0000244|PDB:5TE0}.
FT   STRAND       44     55       {ECO:0000244|PDB:5TE0}.
FT   STRAND       58     64       {ECO:0000244|PDB:5TE0}.
FT   STRAND       70     78       {ECO:0000244|PDB:5TE0}.
FT   HELIX        81     97       {ECO:0000244|PDB:5TE0}.
FT   STRAND      106    113       {ECO:0000244|PDB:5TE0}.
FT   STRAND      120    127       {ECO:0000244|PDB:5TE0}.
FT   HELIX       134    139       {ECO:0000244|PDB:5TE0}.
FT   TURN        142    144       {ECO:0000244|PDB:5TE0}.
FT   HELIX       148    167       {ECO:0000244|PDB:5TE0}.
FT   STRAND      168    170       {ECO:0000244|PDB:5TE0}.
FT   HELIX       179    181       {ECO:0000244|PDB:5TE0}.
FT   STRAND      182    184       {ECO:0000244|PDB:5TE0}.
FT   STRAND      190    192       {ECO:0000244|PDB:5TE0}.
FT   HELIX       205    208       {ECO:0000244|PDB:5TE0}.
FT   HELIX       210    220       {ECO:0000244|PDB:5TE0}.
FT   HELIX       223    225       {ECO:0000244|PDB:5TE0}.
FT   HELIX       228    231       {ECO:0000244|PDB:5TE0}.
FT   HELIX       242    257       {ECO:0000244|PDB:5TE0}.
FT   TURN        261    264       {ECO:0000244|PDB:4WSQ}.
FT   HELIX       266    271       {ECO:0000244|PDB:5TE0}.
FT   HELIX       284    293       {ECO:0000244|PDB:5TE0}.
FT   TURN        298    300       {ECO:0000244|PDB:5TE0}.
FT   HELIX       304    315       {ECO:0000244|PDB:5TE0}.
FT   HELIX       339    344       {ECO:0000244|PDB:5TE0}.
SQ   SEQUENCE   961 AA;  103885 MW;  1FB44D0FDEF6CAD0 CRC64;
     MKKFFDSRRE QGGSGLGSGS SGGGGSTSGL GSGYIGRVFG IGRQQVTVDE VLAEGGFAIV
     FLVRTSNGMK CALKRMFVNN EHDLQVCKRE IQIMRDLSGH KNIVGYIDSS INNVSSGDVW
     EVLILMDFCR GGQVVNLMNQ RLQTGFTENE VLQIFCDTCE AVARLHQCKT PIIHRDLKVE
     NILLHDRGHY VLCDFGSATN KFQNPQTEGV NAVEDEIKKY TTLSYRAPEM VNLYSGKIIT
     TKADIWALGC LLYKLCYFTL PFGESQVAIC DGNFTIPDNS RYSQDMHCLI RYMLEPDPDK
     RPDIYQVSYF SFKLLKKECP IPNVQNSPIP AKLPEPVKAS EAAAKKTQPK ARLTDPIPTT
     ETSIAPRQRP KAGQTQPNPG ILPIQPALTP RKRATVQPPP QAAGSSNQPG LLASVPQPKP
     QAPPSQPLPQ TQAKQPQAPP TPQQTPSTQA QGLPAQAQAT PQHQQQLFLK QQQQQQQPPP
     AQQQPAGTFY QQQQAQTQQF QAVHPATQKP AIAQFPVVSQ GGSQQQLMQN FYQQQQQQQQ
     QQQQQQLATA LHQQQLMTQQ AALQQKPTMA AGQQPQPQPA AAPQPAPAQE PAIQAPVRQQ
     PKVQTTPPPA VQGQKVGSLT PPSSPKTQRA GHRRILSDVT HSAVFGVPAS KSTQLLQAAA
     AEASLNKSKS ATTTPSGSPR TSQQNVYNPS EGSTWNPFDD DNFSKLTAEE LLNKDFAKLG
     EGKHPEKLGG SAESLIPGFQ STQGDAFATT SFSAGTAEKR KGGQTVDSGL PLLSVSDPFI
     PLQVPDAPEK LIEGLKSPDT SLLLPDLLPM TDPFGSTSDA VIEKADVAVE SLIPGLEPPV
     PQRLPSQTES VTSNRTDSLT GEDSLLDCSL LSNPTTDLLE EFAPTAISAP VHKAAEDSNL
     ISGFDVPEGS DKVAEDEFDP IPVLITKNPQ GGHSRNSSGS SESSLPNLAR SLLLVDQLID
     L
//
